Stockholm-based Tandem Health, which makes an AI copilot that generates medical notes during consultations, raised a $100M Series B led by Scaleup Europe Fund

AI medical scribes become more sophisticated, potentially reducing physician administrative burden by 50%.

Stockholm-based Tandem Health, an AI healthtech startup, has secured $100 million in Series B funding, led by the EU-backed Scaleup Europe Fund. This round also includes participation from existing investors Kinnevik, Northzone, Amino Collective, and Visionaries. The substantial Series B funding brings Tandem Health's total raised capital to $160 million, following its $50 million Series A round in 2025. The company develops an AI copilot designed to generate medical notes automatically during patient consultations. Tandem Health has not disclosed the valuation at which this latest funding round was completed.

This significant funding infusion for Tandem Health underscores the growing investor confidence in AI-powered solutions for healthcare administration. The Scaleup Europe Fund's lead investment signals a strategic push to bolster European healthtech innovation and potentially accelerate the adoption of AI in clinical settings across the continent. Tandem Health's technology, which automates the creation of medical notes during consultations, directly addresses a major pain point for physicians: the excessive time spent on documentation.

The success of this Series B round positions Tandem Health to scale its operations and further develop its AI copilot, likely enhancing its capabilities in understanding complex medical conversations and generating more accurate, nuanced notes. Other healthtech companies focusing on AI-driven administrative tools may see increased competition and a heightened need to demonstrate similar technological advancements and market traction to attract future investment.